Weil advised the finance parties, in connection with Mehiläinen’s (majority owned by CVC and Hellman & Friedman) (i) offering of €350 million aggregate principal amount of senior secured floating rate notes due 2032 with a coupon of three-month EURIBOR (subject to a zero floor), plus 3.375% and €740 million aggregate principal amount of its 5.125% senior secured fixed rate notes due 2032, (ii) repricing of its existing €1.86 billion term facilities and (iii) upsizing of its existing revolving credit facility by €150 million.

The proceeds from the offering will be used to complete the previously announced acquisitions of Centrul Medical Unirea S.R.L. and its subsidiaries (“Regina Maria”), and Mino Holdings S.à r.l. and its subsidiaries (“MediGroup”), and to pay certain costs, expenses and fees related to this offering and the acquisitions. If the acquisition of MediGroup is not completed for any reason following the consummation of the acquisition of Regina Maria, the Company will use any excess proceeds for general corporate purposes. The proceeds of the notes will initially be deposited into an escrow account and will be released in connection with the completion of the acquisition of Regina Maria.

Mehiläinen is the largest healthcare and social care provider in Finland with a fast-growing international presence.

The Weil team was led by Finance partner Alastair McVeigh and High Yield partner Gilles Teerlinck, and included Finance counsel Marcus Chaplin-Roberts, High Yield counsel Pierre Brule and associates Ryan Prithraj, David St-Onge and Delphine Collinet in London, with Tax advice provided by partners Greg Featherman and Oliver Walker, counsel Akash Mehta and associates Carlos Parra and Anna Ritchie.